These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27383869)

  • 21. Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.
    Grimaldi M; Karaca M; Latini L; Brioudes E; Schalch T; Maechler P
    Hum Mol Genet; 2017 Sep; 26(18):3453-3465. PubMed ID: 28911206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome.
    Bahi-Buisson N; Roze E; Dionisi C; Escande F; Valayannopoulos V; Feillet F; Heinrichs C; Chadefaux-Vekemans B; Dan B; de Lonlay P
    Dev Med Child Neurol; 2008 Dec; 50(12):945-9. PubMed ID: 19046187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation in GLUD1 causing hyperinsulinism-hyperammonemia in a patient with high density of homozygosity on microarray: a case report.
    Odom J; Gieron-Korthals M; Shulman D; Newkirk P; Prijoles E; Sanchez-Valle A
    J Med Case Rep; 2016 Feb; 10():25. PubMed ID: 26839063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome.
    Boodhansingh KE; Rosenfeld E; Lord K; Adzick NS; Bhatti T; Ganguly A; De Leon DD; Stanley CA
    Horm Res Paediatr; 2022; 95(5):492-498. PubMed ID: 35952631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase.
    Luczkowska K; Stekelenburg C; Sloan-Béna F; Ranza E; Gastaldi G; Schwitzgebel V; Maechler P
    Hum Genomics; 2020 Mar; 14(1):9. PubMed ID: 32143698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome.
    Santer R; Kinner M; Passarge M; Superti-Furga A; Mayatepek E; Meissner T; Schneppenheim R; Schaub J
    Hum Genet; 2001 Jan; 108(1):66-71. PubMed ID: 11214910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel missense mutations in the glutamate dehydrogenase gene in the congenital hyperinsulinism-hyperammonemia syndrome.
    Miki Y; Taki T; Ohura T; Kato H; Yanagisawa M; Hayashi Y
    J Pediatr; 2000 Jan; 136(1):69-72. PubMed ID: 10636977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations.
    Raizen DM; Brooks-Kayal A; Steinkrauss L; Tennekoon GI; Stanley CA; Kelly A
    J Pediatr; 2005 Mar; 146(3):388-94. PubMed ID: 15756227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial GTP insensitivity contributes to hypoglycemia in hyperinsulinemia hyperammonemia by inhibiting glucagon release.
    Kibbey RG; Choi CS; Lee HY; Cabrera O; Pongratz RL; Zhao X; Birkenfeld AL; Li C; Berggren PO; Stanley C; Shulman GI
    Diabetes; 2014 Dec; 63(12):4218-29. PubMed ID: 25024374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hyperinsulinism/hyperammonemia syndrome.
    Palladino AA; Stanley CA
    Rev Endocr Metab Disord; 2010 Sep; 11(3):171-8. PubMed ID: 20936362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperinsulinism and hyperammonaemia syndrome due to a novel missense mutation in the allosteric domain of the glutamate dehydrogenase 1 gene.
    Chik KK; Chan CW; Lam CW; Ng KL
    J Paediatr Child Health; 2008 Sep; 44(9):517-9. PubMed ID: 18928469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological aspects in hyperinsulinism-hyperammonaemia syndrome.
    Kelly A; Stanley CA
    Dev Med Child Neurol; 2008 Dec; 50(12):888. PubMed ID: 19046183
    [No Abstract]   [Full Text] [Related]  

  • 33. Two genetic forms of hyperinsulinemic hypoglycemia caused by dysregulation of glutamate dehydrogenase.
    Stanley CA
    Neurochem Int; 2011 Sep; 59(4):465-72. PubMed ID: 21130127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperinsulinism-hyperammonemia Syndrome in an Infant with Seizures.
    Strajnar A; Tansek MZ; Podkrajsek KT; Battelino T; Groselj U
    Balkan J Med Genet; 2018 Jun; 21(1):77-81. PubMed ID: 30425915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome.
    Hsu BY; Kelly A; Thornton PS; Greenberg CR; Dilling LA; Stanley CA
    J Pediatr; 2001 Mar; 138(3):383-9. PubMed ID: 11241047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome.
    Rosenfeld E; Nanga RPR; Lucas A; Revell AY; Thomas A; Thomas NH; Roalf DR; Shinohara RT; Reddy R; Davis KA; De León DD
    Orphanet J Rare Dis; 2022 Jun; 17(1):248. PubMed ID: 35752848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intractable absence seizures in hyperinsulinism-hyperammonemia syndrome.
    Nakano K; Kobayashi K; Okano Y; Aso K; Ohtsuka Y
    Pediatr Neurol; 2012 Aug; 47(2):119-22. PubMed ID: 22759688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary alpha-ketoglutarate is elevated in patients with hyperinsulinism-hyperammonemia syndrome.
    Meissner T; Mayatepek E; Kinner M; Santer R
    Clin Chim Acta; 2004 Mar; 341(1-2):23-6. PubMed ID: 14967154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PNC2 (SLC25A36) Deficiency Associated With the Hyperinsulinism/Hyperammonemia Syndrome.
    Shahroor MA; Lasorsa FM; Porcelli V; Dweikat I; Di Noia MA; Gur M; Agostino G; Shaag A; Rinaldi T; Gasparre G; Guerra F; Castegna A; Todisco S; Abu-Libdeh B; Elpeleg O; Palmieri L
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1346-1356. PubMed ID: 34971397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamate Dehydrogenase as a Promising Target for Hyperinsulinism Hyperammonemia Syndrome Therapy.
    Bian Y; Hou W; Chen X; Fang J; Xu N; Ruan BH
    Curr Med Chem; 2022; 29(15):2652-2672. PubMed ID: 34525914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.